Journal of Parkinsons Disease

Papers
(The H4-Index of Journal of Parkinsons Disease is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Introduction: The Earliest Phase of Parkinson’s Disease: Possibilities for Detection and Intervention87
One-year practice effects predict long-term cognitive outcomes in Parkinson's disease86
This is NOT the End for Immunotherapy in Parkinson’s Disease – A Perspective from Early Drug Development Scientists83
Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression78
Levodopa-Induced dyskinesia in Latin America: Prevalence and associated clinical factors in the LARGE-PD cohort77
Evolution of disease modifying therapy clinical trial design and therapeutic endpoints for Parkinson's disease72
Clinical Trial Highlights: Modulators of Mitochondrial Function63
Acknowledgment to reviewers 202561
When Parkinson's disease interferes in a couple's life: A qualitative study61
A framework to standardize gait study protocols in Parkinson's disease60
Creation of a machine learning-based model for early identification of mild cognitive impairment risk in Parkinson's disease: A PD research center-based population study55
Chronotropic Incompetence in Parkinson’s Disease: A Possible Marker of Severe Disease Phenotype?52
Feasibility and potential effectiveness of an exergame program for people with moderate to advanced Parkinson's disease: A pilot randomized controlled trial51
A prospective analysis of falls in Parkinson's disease: Does physical capacity moderate the relationship between walking amount and falls rates?51
Reply to the Letter to the Editor: Stefani A, “Is it too early to Underrate Genetic onto PD Pathogenesis? Reflections on History”51
May Bradykinesia Features Aid in Distinguishing Parkinson’s Disease, Essential Tremor, And Healthy Elderly Individuals?46
Jellinger K, “Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same”43
Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson’s Disease42
What medicines do people with Parkinson's disease want?41
Cerebral Small Vessel Disease Is Associated with Motor, Cognitive, and Emotional Dysfunction in Multiple System Atrophy41
A Coalition to Advance Treatments for Parkinson’s Disease, Dementia with Lewy Bodies, and Related Disorders40
Rapid Voluntary Blinking as a Clinical Marker of Parkinson’s Disease40
Effects of Very Low- and High-Frequency Subthalamic Stimulation on Motor Cortical Oscillations During Rhythmic Lower-Limb Movements in Parkinson’s Disease Patients39
Are Preformed Fibrils a Model of Parkinson’s Disease?37
Real-World Evaluation of the Feasibility, Acceptability and Safety of a Remote, Self-Management Parkinson’s Disease Care Pathway: A Healthcare Improvement Initiative36
Apathy Reflects Extra-Striatal Dopaminergic Degeneration in de novo Parkinson’s Disease34
Early-Onset Parkinson’s Disease: Creating the Right Environment for a Genetic Disorder33
Atrophy-related corticospinal changes in advanced Parkinson's disease are associated with the genetic etiology of the disease33
The Role of Microelectrode Recording and Stereotactic Computed Tomography in Verifying Lead Placement During Awake MRI-Guided Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease31
Is There an Association Between Parkinson’s Disease and Periodontitis? A Systematic Review and Meta-Analysis30
Anxiety is associated with increased risk of suicidality in Parkinson's disease30
The fixel GI Parkinson's research and integrated support model (PRISM)30
0.54970502853394